Zika Patients May Face a Poorer COVID-19 Prognosis

Zika patients may face a poorer COVID-19 prognosis

Despite limited research, coinfections involving SARS-CoV-2 and orthoflaviviruses, including Zika virus, have been reported in Mexico. Intriguingly, such coinfections may also occur in other countries with a history of Zika epidemics, including Brazil. However, the clinical characteristics and potential outcomes of Zika patients coinfected with SARS-CoV-2 remain unknown. In the upcoming hypothesis, I reanalyze proteomics profile of Zika virus (ZIKV)-infected cells and propose two potential players that may implicate to worsening COVID-19 prognosis—Stay tuned!